UCSF Assistant Professor Honored with 2025 Dr. Nanette K. Wenger Research Goes Red® Award

In a landmark recognition at the American Heart Association’s Scientific Sessions 2025, Dr. Megan McLaughlin, M.D., M.P.H., an accomplished cardiologist and assistant professor at the University of California, San Francisco, has been honored with the prestigious 2025 Dr. Nanette K. Wenger Research Goes Red® Award. This accolade celebrates groundbreaking contributions to cardiovascular disease research specifically focused on women, highlighting the critical intersection between women’s health and heart disease prevention. The annual meeting, a global nexus for the latest cardiovascular scientific data and clinical practices, will formally present this award during a dedicated session on November 8 in New Orleans.

The award, named after Dr. Nanette K. Wenger—a trailblazing figure in women’s cardiovascular health—recognizes the most exemplary scientific article on cardiovascular disease and stroke in women published in the past year within the American Heart Association’s extensive network of peer-reviewed journals. Dr. Wenger’s pioneering work has shaped the foundational understanding and advocacy for heart disease in women, making this award a significant hallmark of excellence. The Research Goes Red® initiative, which the award complements, empowers women researchers and clinicians to advance scientific knowledge and champion heart health among women.

Dr. McLaughlin’s acclaimed article, “Disparities in Postpartum Care After a Hypertensive Disorder of Pregnancy in the United States,” published earlier this year in the journal Hypertension, delves into the often-overlooked postpartum care discrepancies following hypertensive pregnancy disorders. These disorders, which include conditions such as preeclampsia and gestational hypertension, are well-known precursors for chronic cardiovascular illness later in life. Her rigorous study analyzed nationally representative data from over 47,000 postpartum individuals, unearthing profound variations in postpartum healthcare engagement tied closely to racial, ethnic, insurance, and socioeconomic factors.

The investigative findings revealed that while the majority of patients attend postpartum visits, the quality and comprehensiveness of care, including essential counseling and cardiovascular risk screenings, are frequently inconsistent. Critical interventions such as lifestyle modification guidance, smoking cessation support, and diabetes screening were not uniformly provided. This oversight highlights a glaring, systemic missed opportunity to mitigate long-term cardiovascular risk in an exceptionally vulnerable population, emphasizing a pressing need for standardized postpartum cardiovascular risk management.

Experts within the field, including Dr. Stacey E. Rosen, the American Heart Association’s current president, have underscored the vital importance of Dr. McLaughlin’s work. Dr. Rosen emphasized how targeted early interventions during and after pregnancy could act as pivotal preventive measures against the progression of heart disease in women at elevated risk. This research advocates for enhanced clinical protocols and educational initiatives that can equip women with the necessary tools to manage their cardiovascular health actively, particularly within high-risk demographics.

The comprehensive peer review process for the 2025 Dr. Nanette K. Wenger Research Goes Red for Women Award was highly competitive, involving 25 leading experts who rigorously evaluated 123 submissions from 17 countries. The selection criteria prioritized scientific impact, innovative methodology, and the robustness of data supporting plausible hypotheses and conclusions. Dr. McLaughlin’s manuscript stood out for its methodical approach and real-world implications, rooted in the synthesis of large-scale epidemiological data with clinical practice relevance.

Dr. McLaughlin expressed her profound admiration for Dr. Wenger’s legacy and shared her commitment to advancing cardiovascular disease research tailored specifically to women. Her clinical focus encompasses heart disease prevention, advanced echocardiography, and the development of strategies to preempt heart disease in women facing pregnancy complications. Her multidimensional approach bridges clinical cardiology and public health, aiming to close gaps in both understanding and care delivery.

Her past accolades include prestigious recognitions such as the 2023 American Heart Association Get With the Guidelines® Early Career Investigator Database Research Seed Grant and distinctions from global bodies like the World Heart Federation. Moreover, Dr. McLaughlin’s leadership extends beyond research as she actively participates in notable cardiovascular councils and committees driving policy and clinical guideline development, reinforcing her influential role in shaping the future of women’s cardiovascular health.

The significance of this award and Dr. McLaughlin’s research is amplified by the broad public health implications of hypertensive disorders during pregnancy. These complications affect millions worldwide and represent a critical window for effective cardiac risk stratification and intervention. By spotlighting racial and socioeconomic disparities in postpartum care, the study calls for targeted policy actions aiming to rectify healthcare inequities and optimize cardiovascular outcomes for future generations.

Dr. McLaughlin’s rigorous training and academic pedigree, with a medical degree from Harvard Medical School and a master’s in public health from Yale, further underscore her expertise in epidemiological research intertwined with cardiology. Her residency and fellowships at UCSF, including advanced echocardiography, equip her with the specialized skills to both innovate in clinical diagnostics and spearhead research initiatives aimed at improving heart disease prevention strategies among women.

This prestigious recognition, beyond honoring individual excellence, signals a pivotal shift in cardiovascular research towards the inclusion and prioritization of women’s health issues. The American Heart Association continues to lead this charge globally, fostering a research environment that translates scientific breakthroughs into actionable clinical guidelines, patient education, and ultimately, equitable healthcare delivery.

In summary, Dr. Megan McLaughlin’s groundbreaking research elucidates critical gaps in postpartum cardiovascular care among women who have experienced hypertensive disorders of pregnancy. Her findings spotlight systemic disparities that, if addressed, have the potential to significantly reduce future cardiovascular morbidity among high-risk women. The 2025 Dr. Nanette K. Wenger Research Goes Red® Award not only celebrates these contributions but also elevates the discourse on gender-specific cardiovascular health, promising transformative impact on clinical practice and public health policies worldwide.

News Publication Date: September 29, 2025

Web References:

• American Heart Association release: https://newsroom.heart.org/news/ucsf-assistant-professor-to-receive-the-2025-dr-nanette-k-wenger-research-goes-redR-award?preview=c9de72400261a5da979831540deb5e58
• Award information: https://www.ahajournals.org/wenger-award
• Research article: https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.124.24569